Table of contents

Rheumatoid arthritis

• Original article: Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice (28 November, 2019)

  Niels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, Rob Janknegt, Ralph Peeters, Robert B M Landewé
• Original article: Occupational exposure to organic dusts and risk of developing rheumatoid arthritis: findings from a Swedish population-based case–control study (21 November, 2019)

  Anna Ilar, Per Gustavsson, Pernilla Wiebert, Lars Alfredsson
• Original article: Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension (18 October, 2019)

  Gerd R Burmester, Vibeke Strand, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Gregory St John, Susan Boklage, Mark C Genovese
• Short report: Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor (17 October, 2019)

  Hilde Berner Hammer, Tore K Kvien, L Terslev
• Original article: Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique? (17 October, 2019)

  Denis Mongin, Kim Lauper, Carl Turesson, Merete Lund Hetland, Eirik Klami Kristianslund, Tore K Kvien, Maria Jose Santos, Karel Pavelka, Florenzo Iannone, Axel Finckh, Delphine Sophie Courvoisier
• Original article: Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial (1 October, 2019)

  Vibeke Strand, Eduardo Mysler, Robert J Moots, Gene V Wallenstein, Ryan DeMasi, David Gruben, Koshika Soma, Noriko Iikuni, Josef S Smolen, Roy Fleischmann
• Original article: Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study (3 September, 2019)

  Antonia Boman, Mikael Brink, Anders Lundquist, Monica Hansson, Linda Mathsson-Alm, Johan Rönnelid, Ewa Berglin, Rikard Holmdahl, Karl Skriner, Guy Serre, Lars Klareskog, Solbritt Rantapää-Dahlqvist
• Original article: Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment (1 August, 2019)

  Mark C Genovese, Désirée van der Heijde, Yong Lin, Gregory St John, Sheldon Wang, Hubert van Hoogstraten, Juan José Gómez-Reino, Alan Kivitz, José Antonio Maldonado-Cocco, Bruno Seriolo, Marina Stanislav, Gerd R Burmester
• Original article: Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry (30 July, 2019)

  Sytske Anne Bergstra, Maura C Couto, Nimmisha Govind, Arvind Chopra, Karen Salomon Escoto, Elizabeth Murphy, Tom WJ Huizinga, Cornelia F Allaart
• Viewpoint: Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift (27 July, 2019)

  Katerina Chatzidionysiou, Petros P Sfikakis
• Original article: Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis (21 July, 2019)

  Alexandre Virone, Jean-Philippe Bastard, Soraya Fellahi, Jacqueline Capeau, Stéphanie Rouanet, Jean Sibilia, Philippe Ravaud, Francis Berenbaum, Jacques-Eric Gottenberg, Jérémie Sellam
• Original article: Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study (11 July, 2019)

  Anna Ilar, Lars Klareskog, Saedis Saevarsdottir, Pernilla Wiebert, Johan Askling, Per Gustavsson, Lars Alfredsson
• Original article: Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients (14 June, 2019)

  Laure Gossec, Martin Soubrier, Frantz Foissac, Anna Molto, Pascal Richette, Catherine Beauvais, Adeline Ruyssen-Witrand, Aleth Perdriger, Isabelle Chary-Valckenaere, Gael Mouterde, Emanuelle Dernis, Liana Euller-Ziegler, René-Marc Flipo, Mélanie Gilson, Sandrine Guis, Xavier Mariette, Sophie Pouplin, Thierry Marhadour, Thierry Schaeverbeke, Christelle Sordet, Françoise Fayet, Maxime Dougados